EUVIMEDOpdag EUVIMED
Crossref

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first‐time blood donors

Kräuchi Rahel, Schimanski Bernd iD, Tinguely Caroline, Niederhauser Christoph iD, Lejon Crottet Sofia iD, Henny Christine iD

Transfusion · 2026

DOI: 10.1111/trf.70352 ↗

At a glance

Journal article in Transfusion, 2026. Written by Kräuchi Rahel and 5 co-authors. Institution: Interregional Blood Transfusion SRC, Bern, Switzerland. Major MEDLINE topics: Rh-Hr Blood-Group System, Blood Donors, Alleles. 27 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The RH blood group system, particularly the RH1 (D) antigen, is highly immunogenic and clinically significant in transfusion medicine. Standard serological donor RH1 typing may fail to detect very weakly expressed RH1 variants, resulting in a risk of alloimmunization in recipients negative for the corresponding antigen. In 2012, routine molecular screening of RH1‐negative first‐time donors was implemented in Switzerland to improve transfusion safety. In this context, we present three novel RH1 variant alleles discovered through molecular analysis.

Methods

Serological RH phenotyping was performed using column agglutination, adsorption–elution testing, and monoclonal antibody panels. Genomic DNA and RNA were extracted and analyzed by SSP‐PCR, RHD exon sequencing, and cDNA sequencing.

Results

Three previously undescribed RHD variant alleles were identified in four first‐time donors. Two donors carried a nonsense mutation NM_016124.5:c.265C>T resulting in a premature stop codon (NP_057208.2:p.Gln89Ter), associated with an apparent RH1‐negative phenotype but weakly positive adsorption–elution results. One donor carried a missense mutation NM_016124.5:c.863 T>A (NP_057208.2:p.Ile288Asn), associated with extremely weak RH1 expression. In one donor with a true RH1‐negative phenotype, a frameshift mutation NM_016124.5:c.970del was identified, resulting in NP_057208.2:p.His324Thrfs*35 and predicted truncation of the RH1 protein.

Discussion

The findings demonstrate that routine molecular RHD screening of serologically RH1‐negative first‐time donors is essential for the detection of rare RHD variants that may escape serological testing. Molecular characterization of such alleles improves transfusion safety by preventing inadvertent transfusion of RH1‐positive red blood cells to RH1‐negative recipients and contributes to a more comprehensive understanding of RHD genetic diversity.

Subjects

MeSH terms (MEDLINE)

Rh-Hr Blood-Group SystemBlood DonorsAllelesHumansBlood DonationFemaleMaleCodon, NonsenseMutation, MissenseAdult

Substances

Rh-Hr Blood-Group SystemRho(D) antigenCodon, Nonsense

Authors and institutions

  • Interregional Blood Transfusion SRC, Bern, Switzerland.
  • Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

ORCID profiles: Schimanski Bernd, Niederhauser Christoph, Lejon Crottet Sofia, Henny Christine

Cite

APA

Rahel, K., Bernd, S., Caroline, T., Christoph, N., Sofia, L. C., & Christine, H. (2026). Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first‐time blood donors. Transfusion. https://doi.org/10.1111/trf.70352

Vancouver

Rahel K, Bernd S, Caroline T, Christoph N, Sofia LC, Christine H. Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first‐time blood donors. Transfusion. 2026. doi:10.1111/trf.70352

BibTeX
@article{Rahel2026,
  author = {Rahel, Kräuchi and Bernd, Schimanski and Caroline, Tinguely and Christoph, Niederhauser and Sofia, Lejon Crottet and Christine, Henny},
  title = {Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first‐time blood donors},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70352}
}
Start for free →